The effect of consuming the prepared cakes with acorn flour in patients with metabolic syndrome

Phase 3

Conditions: Condition 1: Metabolic syndrome. Condition 2: Obesity due to excess calories.
Metabolic syndrome
Obesity due to excess calories
E88.81
E66.0

Registration Number: IRCT20231104059958N1

Lead Sponsor: Faculty of Veterinary Medicine, Shiraz University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 66

Inclusion Criteria

Patients with metabolic syndrome
Waist circumference greater than 102 cm in men and 88 cm in women
Triglycerides equal to or greater than 150 mg/dL
HDL less than or equal to 40 in men and less than or equal to 50 in women
Blood pressure more than 130 to 85 mm Hg and blood sugar equal to or more than 100 mg/dL
Stable body weight (weight change less than 3 kg in the last 3 months)
Not participating in weight loss programs in the last 6 months

Exclusion Criteria

Diabetic patients receiving blood sugar lowering drugs and insulin
History of alcohol consumption
Smoking
Pregnant and lactating women
People with mental illnesses, cancer, thyroid, cardiovascular, lung, kidney, liver, eating disorders
Taking drugs that affect appetite, body weight, calcium and vitamin D metabolism, and lipid metabolism or have an anti-inflammatory effect.
Taking antioxidants or multivitamins and any type of food supplement
Having lactose intolerance

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Interleukin-6. Timepoint: Before and after the intervention. Method of measurement: ELISA (Enzyme-Linked Immunosorbent Assay ) kit.;C reactive protein. Timepoint: Before and after the intervention. Method of measurement: ELISA (Enzyme-Linked Immunosorbent Assay ) kit.

Secondary Outcome Measures

Name	Time	Method
Malondialdehyde. Timepoint: before and after the intervention. Method of measurement: Thiobarbituric acid method.;Total antioxidant capacity. Timepoint: before and after the intervention. Method of measurement: ElISA (Enzyme-linked immunosorbent assay) kit.;Adiponectin. Timepoint: before and after the intervention. Method of measurement: ElISA (Enzyme-linked immunosorbent assay) kit.